Small intestinal biopsy is diagnostic in which of the following conditions?
What is a highly sensitive and specific marker for detecting intestinal inflammation in ulcerative colitis?
Zollinger-Ellison syndrome is not associated with which of the following?
A patient with a history of diabetes mellitus and hypothyroidism presents with passing stools and failure to gain weight. What is the further diagnostic investigation to be done?
A 40-year-old man with a history of Crohn's disease has recently undergone intestinal resection and developed short bowel syndrome as a complication. Which of the following is not a feature of short bowel syndrome?
What is the best test for diagnosing esophageal varices?
A patient with steatorrhea has microcytic anemia. The 5-hour urine excretion of D-Xylose after a 25 gm oral load is 2.5 gm. What is the most likely diagnosis?
Ingestion of an osmotically active substance can cause osmotic diarrhea. Which of the following can cause osmotic diarrhea?
A patient is admitted with severe pain in the abdomen, nausea, vomiting, and fever. What is the most likely diagnosis?
A patient is being evaluated for jaundice and liver fibrosis. His AST=87 IU/mL and ALT=81 IU/mL. His serological tests are: IgM Anti-HbcAg Non-reactive, IgG Anti-HbcAg Reactive, HbsAg Non-reactive, HBeAg Non-reactive, and Anti-HCV Reactive. Which of the following is the next step in the diagnosis?
Explanation: Small intestinal biopsy is a cornerstone in the evaluation of malabsorption [2]. The diagnostic utility of a biopsy is categorized into conditions where it is **pathognomonic (diagnostic)** versus those where it is **supportive but not specific**. ### Why Option C is Correct In these three conditions, the histological findings are characteristic enough to confirm the diagnosis: 1. **Whipple’s Disease:** Shows pathognomonic **PAS-positive macrophages** in the lamina propria containing *Tropheryma whipplei* bacilli [1]. 2. **Abetalipoproteinemia:** Characterized by **clear, lipid-laden enterocytes** (vacuoles) after a fatty meal, because the body cannot form chylomicrons to transport fat out of the cells. 3. **Celiac Disease:** While it requires clinical correlation, the triad of **villous atrophy, crypt hyperplasia, and increased intraepithelial lymphocytes (IELs)** is considered diagnostic in the presence of positive serology [1]. ### Why Other Options are Incorrect * **Agammaglobulinemia (Options A & B):** While biopsy shows an absence of plasma cells, this is a supportive finding rather than a primary diagnostic tool for the systemic immune deficiency, which is diagnosed via serum electrophoresis and flow cytometry. * **Option D:** This is incomplete. While Whipple's and Abetalipoproteinemia are diagnostic, Celiac disease is also a major condition where biopsy is the gold standard for diagnosis. ### NEET-PG High-Yield Pearls * **Whipple’s Disease:** Look for the "Foamy Macrophage." Remember the clinical triad: Malabsorption, Lymphadenopathy, and Arthritis. * **Celiac Disease:** Biopsy must be taken from the **second part of the duodenum** (D2) or beyond, as changes are most prominent there [1]. Use the **Marsh Classification** for grading. * **Tropical Sprue:** Unlike Celiac, it involves the **entire small intestine** (including the ileum), leading to Vitamin B12 deficiency. * **Giardiasis:** Biopsy may show "pear-shaped" trophozoites, but stool antigen/microscopy is the preferred initial test.
Explanation: **Explanation:** The detection of intestinal inflammation in Ulcerative Colitis (UC) relies on identifying markers released by neutrophils during the inflammatory process. [1] **Why Fecal Lactoferrin is correct:** Lactoferrin is an iron-binding glycoprotein found in the secondary granules of neutrophils. When inflammation occurs in the intestinal mucosa, neutrophils infiltrate the bowel wall and degranulate, releasing lactoferrin into the feces. It is highly stable in stool for several days. Clinical studies have shown that fecal lactoferrin is both **highly sensitive and specific** for identifying active inflammatory bowel disease (IBD) and distinguishing it from non-inflammatory conditions like Irritable Bowel Syndrome (IBS). **Analysis of Incorrect Options:** * **CRP (C-Reactive Protein):** While a common marker, it is a non-specific systemic reactant. It can be elevated in any systemic infection or inflammation and may remain normal in some patients with active UC. * **Fecal Calprotectin:** This is also a highly sensitive marker for IBD (often used interchangeably with lactoferrin). However, in the context of specific exam questions where both are listed, lactoferrin is sometimes highlighted for its slightly higher specificity in certain clinical subsets, though both are clinically excellent. *Note: In many modern guidelines, Calprotectin is more commonly used in practice, but Lactoferrin remains a classic "textbook" correct answer for specificity.* * **Leukocytosis:** An elevated white blood cell count is non-specific and can be influenced by steroids (commonly used in UC treatment), infections, or stress. **NEET-PG High-Yield Pearls:** * **Gold Standard for Diagnosis:** Colonoscopy with biopsy remains the definitive diagnostic tool for UC. [1] * **Monitoring:** Fecal markers (Lactoferrin/Calprotectin) are excellent for monitoring treatment response and predicting relapses non-invasively. * **Differentiation:** These markers are crucial for differentiating **IBD** (Organic) from **IBS** (Functional). * **Stability:** Fecal lactoferrin is resistant to degradation by proteolysis in the gut, making it a reliable stool marker.
Explanation: **Explanation:** Zollinger-Ellison Syndrome (ZES) is caused by a gastrin-secreting neuroendocrine tumor (gastrinoma), typically located in the "gastrinoma triangle" (duodenum, pancreas, or porta hepatis). **Why Option D is the Correct Answer:** The hallmark of ZES is **hypergastrinemia**, which leads to massive hyperplasia of gastric parietal cells. This results in **profoundly increased Basal Acid Output (BAO)**, often exceeding 15 mEq/hr. Therefore, "decreased basal acid secretion" is physiologically incompatible with ZES. **Analysis of Incorrect Options:** * **A. Peptic ulcer disease:** Chronic hypersecretion of gastric acid leads to multiple, refractory, or atypically located ulcers (e.g., in the distal duodenum or jejunum). * **B. Elevated gastrin:** This is the primary pathology. Gastrinomas autonomously secrete high levels of gastrin, which is not suppressed by normal feedback mechanisms. * **C. Non-B islet cell tumor:** Gastrinomas arise from non-beta islet cells of the pancreas or, more commonly, from the neuroendocrine cells in the duodenum. **NEET-PG High-Yield Pearls:** 1. **Diagnosis:** The best initial test is a **fasting serum gastrin level** (>1000 pg/mL is diagnostic). 2. **Confirmatory Test:** The **Secretin Stimulation Test** is the most specific; secretin normally inhibits gastrin but causes a paradoxical *increase* in gastrin levels in ZES patients. 3. **Association:** Approximately 25% of ZES cases are associated with **Multiple Endocrine Neoplasia type 1 (MEN1)**. 4. **Clinical Feature:** Apart from ulcers, **steatorrhea/diarrhea** is common because the low intestinal pH inactivates pancreatic lipases.
Explanation: ### Explanation **Correct Option: A. Anti-Gliadin Antibody** The clinical presentation of a patient with **Diabetes Mellitus (Type 1)** and **Hypothyroidism** (likely Hashimoto’s) suggests a background of **Autoimmune Polyendocrine Syndrome (APS)** [1]. These patients have a significantly higher risk of developing **Celiac Disease**, another autoimmune condition, as the genes associated with type 1 diabetes overlap with those for celiac and thyroid disease [2]. The symptoms of "passing stools" (chronic diarrhea) and "failure to gain weight" (malabsorption) in a patient with pre-existing autoimmune diseases are classic indicators of Celiac Disease [3]. Screening for Celiac Disease is performed using serological markers. While **Anti-Tissue Transglutaminase (tTG) IgA** is currently the gold standard for screening, **Anti-Gliadin Antibody** is a recognized marker in this clinical context for NEET-PG purposes. **Why other options are incorrect:** * **B. Thyroid Function Test (TFT):** While the patient has hypothyroidism, the primary complaint is gastrointestinal (malabsorption). TFTs would monitor his thyroid status but wouldn't diagnose the cause of weight loss and diarrhea. * **C. Stool microscopy:** This is useful for identifying parasites or infections, but the systemic autoimmune history points more strongly toward a malabsorptive disorder like Celiac Disease. * **D. 72-hour fecal fat collection:** This is the gold standard for *confirming* steatorrhea, but it does not provide an etiological diagnosis. Serology is the preferred initial diagnostic step. --- ### Clinical Pearls for NEET-PG * **Associations:** Celiac disease is strongly associated with **HLA-DQ2 and HLA-DQ8** [3]. * **Gold Standard Diagnosis:** Small intestinal biopsy showing **villous atrophy**, crypt hyperplasia, and increased intraepithelial lymphocytes (Marsh Classification) [3]. * **Best Initial Test:** IgA Anti-tissue Transglutaminase (tTG) antibody. (Note: Always check total IgA levels to rule out IgA deficiency). * **Dermatological Link:** **Dermatitis Herpetiformis** is the pathognomonic skin manifestation of Celiac Disease.
Explanation: **Explanation:** Short Bowel Syndrome (SBS) occurs when there is a significant loss of functioning small intestine, leading to malabsorption [1]. **Why Hypogastrinemia is the Correct Answer:** In SBS, patients actually develop **Hypergastrinemia**, not hypogastrinemia. The loss of the small intestine leads to the reduced secretion of inhibitory hormones (like secretin and gastric inhibitory peptide) that normally downregulate gastrin. This results in gastric acid hypersecretion, which can exacerbate diarrhea by inactivating pancreatic enzymes and damaging the intestinal mucosa. **Analysis of Incorrect Options:** * **Steatorrhea:** This is a hallmark of SBS. The loss of the ileum leads to a depleted bile acid pool (due to interrupted enterohepatic circulation) and a reduced surface area for fat absorption, resulting in fatty stools [2]. * **Diarrhea:** This occurs due to multiple factors: the osmotic effect of undigested nutrients, gastric acid hypersecretion, and the presence of unabsorbed bile acids in the colon (choleretic diarrhea) [1]. * **Kidney Stones:** Specifically, **Calcium Oxalate stones** are common. Normally, calcium binds to oxalate in the gut to be excreted. In SBS, calcium binds to unabsorbed fats instead. This leaves "free oxalate" to be excessively absorbed in the colon (enteric hyperoxaluria) and subsequently precipitated in the kidneys. **High-Yield Clinical Pearls for NEET-PG:** * **Most common site for Vitamin B12 and Bile Acid absorption:** Terminal Ileum (loss leads to megaloblastic anemia and steatorrhea). * **Gallstones:** Also increased in SBS due to altered bile composition (increased cholesterol saturation). * **Management:** Initial management involves TPN, followed by enteral adaptation. Drugs like **Teduglutide** (GLP-2 analogue) can help improve intestinal absorption.
Explanation: **Gastroesophagoscopy (Upper GI Endoscopy)** is the gold standard and investigation of choice for diagnosing esophageal varices [1]. The underlying medical concept is direct visualization: endoscopy allows the clinician to not only confirm the presence of dilated submucosal veins but also to grade their size and identify high-risk markers for bleeding, such as "red wale" markings or cherry-red spots [1]. Furthermore, it offers immediate therapeutic potential through Endoscopic Variceal Ligation (EVL) or sclerotherapy. **Why other options are incorrect:** * **CT Scan:** While modern MDCT can detect large varices and provide information on collateral circulation (like splenorenal shunts), it lacks the sensitivity to detect small varices and cannot be used for therapeutic intervention. * **Tomography:** This is a general term for sectional imaging. Standard tomography is obsolete for this purpose and lacks the mucosal detail required to assess variceal bleed risk. * **Ultrasound:** Transabdominal ultrasound is excellent for diagnosing the *cause* of varices (e.g., cirrhosis, portal vein thrombosis, or splenomegaly) and detecting portal hypertension via Doppler, but it cannot reliably visualize the esophageal lumen to diagnose varices directly. **Clinical Pearls for NEET-PG:** * **Primary Prophylaxis:** All patients with cirrhosis should undergo screening endoscopy to check for varices. * **Drug of Choice:** Non-selective beta-blockers (Propranolol/Nadolol) are used for primary prophylaxis to reduce portal pressure. * **Acute Bleed Management:** The first-line medical treatment for active variceal hemorrhage is **Octreotide** or Terlipressin, followed by urgent endoscopy within 12–24 hours. * **Child-Pugh Score:** Remember that the severity of liver disease correlates with the risk of variceal bleeding.
Explanation: ### Explanation The key to solving this question lies in interpreting the **D-Xylose absorption test** and the type of **anemia**. **1. Why Celiac Sprue is correct:** D-Xylose is a monosaccharide that is absorbed in the proximal small intestine (duodenum and jejunum) without requiring pancreatic enzymes. * **Low urinary excretion (<4.5 g/5 hours)** indicates **mucosal malabsorption** in the proximal small bowel [1]. * **Microcytic anemia** (Iron deficiency) is a hallmark of **Celiac sprue** because iron is primarily absorbed in the duodenum, which is the site of maximal damage (villous atrophy) in Celiac disease [1]. **2. Why other options are incorrect:** * **Chronic Pancreatitis:** This causes maldigestion due to enzyme deficiency. Since D-Xylose does not require pancreatic enzymes for absorption, the test result would be **normal** (>4.5 g) [1]. * **Tropical Sprue:** While this also causes a low D-Xylose test, it typically involves the entire small bowel, including the ileum. This leads to Vitamin B12 deficiency, resulting in **macrocytic anemia**, not microcytic. * **Ileal Resection:** The ileum is the site for Vitamin B12 and bile acid absorption. D-Xylose is absorbed proximally; therefore, isolated ileal resection usually results in a **normal** D-Xylose test and macrocytic anemia. **3. NEET-PG High-Yield Pearls:** * **D-Xylose Test:** Used to differentiate mucosal disease (Low) from pancreatic insufficiency (Normal) [1]. * **False Positives:** D-Xylose levels can be low in SIBO (bacteria metabolize the sugar), renal dysfunction, or delayed gastric emptying [2]. * **Celiac Disease Triad:** Steatorrhea + Iron Deficiency Anemia + Proximal small bowel mucosal biopsy findings (Villous atrophy, Crypt hyperplasia) [1]. * **Gold Standard Diagnosis for Celiac:** Intestinal biopsy; **Screening:** Anti-tissue Transglutaminase (anti-tTG) IgA antibodies [1].
Explanation: Diarrhea is broadly classified into osmotic and secretory types based on the underlying mechanism. **1. Why Disaccharidase Deficiency is Correct:** Osmotic diarrhea occurs when non-absorbable, water-soluble solutes remain in the intestinal lumen, creating an osmotic gradient that pulls water from the plasma into the gut [1]. In **Disaccharidase deficiency** (e.g., Lactase deficiency), undigested carbohydrates (lactose) cannot be absorbed [3]. These sugars remain in the lumen, exert an osmotic effect, and are fermented by colonic bacteria into short-chain fatty acids and gases, further worsening the diarrhea [1], [3]. A key feature is that the diarrhea **stops with fasting** and has an **increased stool osmotic gap** (>125 mOsm/kg). **2. Why Other Options are Incorrect:** * **Phenolphthalein, Bisacodyl, and Castor oil:** These are all classified as **Stimulant Laxatives**. They cause **Secretory Diarrhea** by actively stimulating the intestinal mucosa to secrete water and electrolytes (like Sodium and Chloride) into the lumen or by inhibiting their absorption. Secretory diarrhea typically persists during fasting and has a **low stool osmotic gap** (<50 mOsm/kg). **High-Yield Clinical Pearls for NEET-PG:** * **Stool Osmotic Gap Formula:** $290 - 2 \times (\text{Stool } Na^+ + \text{Stool } K^+)$. * **Osmotic Diarrhea:** Gap >125 mOsm/kg; pH is usually acidic (<5.5) due to bacterial fermentation. * **Secretory Diarrhea:** Gap <50 mOsm/kg; pH is usually neutral. * **Common Causes of Osmotic Diarrhea:** Lactulose, Magnesium salts (antacids), and Celiac disease (malabsorption) [2].
Explanation: **Explanation:** **Acute Pancreatitis** is the most likely diagnosis because it classically presents with the triad of severe, constant epigastric pain (often radiating to the back), systemic symptoms like fever, and significant gastrointestinal distress (nausea/vomiting) [1]. The pain is typically sudden in onset and relieved by leaning forward (the "Mohammedan position"). **Analysis of Options:** * **Perforated Peptic Ulcer:** While it causes sudden, severe pain, it typically results in "board-like" abdominal rigidity due to chemical peritonitis. The pain is usually generalized rather than localized, and an X-ray would show free air under the diaphragm. Note that in contrast to acute pancreatitis, a perforated ulcer typically presents with immediate guarding [1]. * **Intestinal Obstruction:** This presents with colicky (intermittent) pain, abdominal distension, and absolute constipation (obstipation). The vomiting is often feculent in late stages. * **Acute Cholecystitis:** Pain is localized to the Right Upper Quadrant (RUQ) and often radiates to the right scapula. While it causes fever and vomiting, the classic Murphy’s sign would be positive, and the pain is rarely as "severe and global" as pancreatitis. **High-Yield Clinical Pearls for NEET-PG:** * **Diagnosis:** Requires 2 of 3 criteria: (1) Characteristic abdominal pain, (2) Serum Amylase/Lipase >3x upper limit, (3) Characteristic findings on CECT. * **Most Specific Enzyme:** Serum Lipase (remains elevated longer than amylase). * **Prognostic Markers:** Ranson’s Criteria, APACHE II, and elevated **BUN/Hematocrit** (indicators of third-space fluid loss). Specific prognostic scores include the Glasgow criteria [1]. * **Imaging:** CECT is the gold standard but is best performed 48–72 hours after symptom onset to assess necrosis [1]. Earlier ultrasound can be used to identify gallstones [1].
Explanation: ### Explanation The patient presents with elevated transaminases (AST > ALT), jaundice, and fibrosis, indicating chronic liver disease. To determine the etiology, we must interpret the serological markers provided: 1. **Hepatitis C Status:** The patient is **Anti-HCV Reactive**. This indicates either a current (active) infection or a resolved past infection [1]. To differentiate between the two and confirm active viremia, the gold standard next step is a quantitative **HCV-RNA-PCR** [1]. 2. **Hepatitis B Status:** * **HBsAg Non-reactive** and **IgM Anti-HBc Non-reactive** rule out acute or chronic active HBV infection [2]. * **IgG Anti-HBc Reactive** indicates a **past exposure** to HBV (natural infection) [2]. Since HBsAg is negative, the virus has been cleared (or is in an occult state), making HBV an unlikely cause of the current jaundice. #### Why other options are incorrect: * **HBV DNA:** Not indicated as HBsAg is negative; there is no evidence of active HBV replication [2]. * **Anti-HBsAg:** While this would confirm immunity (recovery) from HBV, it does not help diagnose the cause of the current liver injury. * **Liver Biopsy:** Though it can assess the degree of fibrosis, it is not the "next step" in diagnostic workup. Non-invasive viral confirmation must precede invasive procedures. #### NEET-PG High-Yield Pearls: * **HCV Screening:** Anti-HCV is the screening test; HCV-RNA is the confirmatory test [1]. * **Window Period:** In acute HBV, if both HBsAg and Anti-HBs are negative, **IgM Anti-HBc** is the only positive marker (the "Window Period") [2]. * **Isolated IgG Anti-HBc:** Can signify a resolved infection (if Anti-HBs is positive), a false positive, or occult HBV. * **AST/ALT Ratio:** In most chronic viral hepatitis, ALT > AST [3]. However, if **AST > ALT**, suspect progression to **cirrhosis** or an alcoholic etiology.
Esophageal Disorders
Practice Questions
Peptic Ulcer Disease
Practice Questions
Inflammatory Bowel Disease
Practice Questions
Irritable Bowel Syndrome
Practice Questions
Malabsorption Syndromes
Practice Questions
Pancreatitis (Acute and Chronic)
Practice Questions
Gastrointestinal Bleeding
Practice Questions
Liver Diseases and Cirrhosis
Practice Questions
Viral Hepatitis
Practice Questions
Biliary Tract Disorders
Practice Questions
Gastrointestinal Motility Disorders
Practice Questions
Gastrointestinal Malignancies
Practice Questions
Get full access to all questions, explanations, and performance tracking.
Start For Free